KR200492213Y1 - 은 나노 항균막, 그를 포함하는 의료용 영상 촬영장비 - Google Patents
은 나노 항균막, 그를 포함하는 의료용 영상 촬영장비 Download PDFInfo
- Publication number
- KR200492213Y1 KR200492213Y1 KR2020190004678U KR20190004678U KR200492213Y1 KR 200492213 Y1 KR200492213 Y1 KR 200492213Y1 KR 2020190004678 U KR2020190004678 U KR 2020190004678U KR 20190004678 U KR20190004678 U KR 20190004678U KR 200492213 Y1 KR200492213 Y1 KR 200492213Y1
- Authority
- KR
- South Korea
- Prior art keywords
- silver nano
- medical imaging
- antibacterial film
- silver
- light
- Prior art date
Links
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 196
- 239000004332 silver Substances 0.000 title claims abstract description 196
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 78
- 239000002120 nanofilm Substances 0.000 title 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 191
- 238000002059 diagnostic imaging Methods 0.000 claims abstract description 82
- 230000003287 optical effect Effects 0.000 claims abstract description 18
- 238000000576 coating method Methods 0.000 claims abstract description 17
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 claims description 29
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 25
- 230000001678 irradiating effect Effects 0.000 claims description 19
- 239000011248 coating agent Substances 0.000 claims description 12
- 210000001015 abdomen Anatomy 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims 1
- 239000002086 nanomaterial Substances 0.000 abstract description 4
- 208000015181 infectious disease Diseases 0.000 description 23
- 238000002591 computed tomography Methods 0.000 description 17
- 230000002458 infectious effect Effects 0.000 description 17
- 230000005855 radiation Effects 0.000 description 16
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 14
- 239000000126 substance Substances 0.000 description 13
- 238000002156 mixing Methods 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 11
- 239000011259 mixed solution Substances 0.000 description 11
- 241000588724 Escherichia coli Species 0.000 description 9
- 230000000845 anti-microbial effect Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000002105 nanoparticle Substances 0.000 description 6
- 241000588626 Acinetobacter baumannii Species 0.000 description 5
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 5
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 5
- 206010041925 Staphylococcal infections Diseases 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 108010059993 Vancomycin Proteins 0.000 description 5
- 230000003187 abdominal effect Effects 0.000 description 5
- 230000005484 gravity Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 5
- 229960003085 meticillin Drugs 0.000 description 5
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 5
- 229960003165 vancomycin Drugs 0.000 description 5
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 5
- 206010011409 Cross infection Diseases 0.000 description 4
- 206010029803 Nosocomial infection Diseases 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- -1 silver ions Chemical class 0.000 description 4
- 238000011109 contamination Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 238000013441 quality evaluation Methods 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 101710134784 Agnoprotein Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000013170 computed tomography imaging Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 150000002453 idose derivatives Chemical class 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002697 interventional radiology Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000012285 ultrasound imaging Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/44—Constructional features of apparatus for radiation diagnosis
- A61B6/4423—Constructional features of apparatus for radiation diagnosis related to hygiene or sterilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
- A61L2/232—Solid substances, e.g. granules, powders, blocks, tablets layered or coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
- A61L2/238—Metals or alloys, e.g. oligodynamic metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/24—Medical instruments, e.g. endoscopes, catheters, sharps
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- High Energy & Nuclear Physics (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR2020190004678U KR200492213Y1 (ko) | 2019-11-20 | 2019-11-20 | 은 나노 항균막, 그를 포함하는 의료용 영상 촬영장비 |
| PCT/KR2020/016492 WO2021101321A1 (fr) | 2019-11-20 | 2020-11-20 | Film antimicrobien de nano-argent et équipement d'imagerie médicale le comprenant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR2020190004678U KR200492213Y1 (ko) | 2019-11-20 | 2019-11-20 | 은 나노 항균막, 그를 포함하는 의료용 영상 촬영장비 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR200492213Y1 true KR200492213Y1 (ko) | 2020-08-28 |
Family
ID=72234015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR2020190004678U KR200492213Y1 (ko) | 2019-11-20 | 2019-11-20 | 은 나노 항균막, 그를 포함하는 의료용 영상 촬영장비 |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR200492213Y1 (fr) |
| WO (1) | WO2021101321A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021101321A1 (fr) * | 2019-11-20 | 2021-05-27 | 안균흥 | Film antimicrobien de nano-argent et équipement d'imagerie médicale le comprenant |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR200407652Y1 (ko) * | 2005-11-14 | 2006-02-01 | (주)휴비딕 | 은나노 항균 체온계 |
| KR20060069534A (ko) * | 2004-12-17 | 2006-06-21 | 양원동 | 나노실버와 향이 함유된 혈압계 |
| KR20090107430A (ko) * | 2008-04-08 | 2009-10-13 | 바이엘 머티리얼사이언스 아게 | 항균 폴리우레탄 코팅을 갖는 의료 기구 |
| JP2015027416A (ja) * | 2013-01-30 | 2015-02-12 | 富士フイルム株式会社 | 放射線撮影装置 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6588549B2 (ja) * | 2015-07-21 | 2019-10-09 | 富士フイルム株式会社 | 医療用機器 |
| KR200492213Y1 (ko) * | 2019-11-20 | 2020-08-28 | 안균흥 | 은 나노 항균막, 그를 포함하는 의료용 영상 촬영장비 |
-
2019
- 2019-11-20 KR KR2020190004678U patent/KR200492213Y1/ko active IP Right Grant
-
2020
- 2020-11-20 WO PCT/KR2020/016492 patent/WO2021101321A1/fr active Application Filing
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060069534A (ko) * | 2004-12-17 | 2006-06-21 | 양원동 | 나노실버와 향이 함유된 혈압계 |
| KR200407652Y1 (ko) * | 2005-11-14 | 2006-02-01 | (주)휴비딕 | 은나노 항균 체온계 |
| KR20090107430A (ko) * | 2008-04-08 | 2009-10-13 | 바이엘 머티리얼사이언스 아게 | 항균 폴리우레탄 코팅을 갖는 의료 기구 |
| JP2015027416A (ja) * | 2013-01-30 | 2015-02-12 | 富士フイルム株式会社 | 放射線撮影装置 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021101321A1 (fr) * | 2019-11-20 | 2021-05-27 | 안균흥 | Film antimicrobien de nano-argent et équipement d'imagerie médicale le comprenant |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021101321A1 (fr) | 2021-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20180214098A1 (en) | Anatomical imaging system with centipede belt drive | |
| Edis et al. | “Smart” antimicrobial nanocomplexes with potential to decrease surgical site infections (SSI) | |
| EP1231860B2 (fr) | Appareil de mammographie par tomographie tridimensionnelle associee par ordinateur | |
| KR200492213Y1 (ko) | 은 나노 항균막, 그를 포함하는 의료용 영상 촬영장비 | |
| CN112426165A (zh) | 设备、保护片及抗菌膜 | |
| Koomanachai et al. | Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model | |
| Gay et al. | Dose reduction with adaptive statistical iterative reconstruction for paediatric CT: phantom study and clinical experience on chest and abdomen CT | |
| Zhang et al. | Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor | |
| Ritschl et al. | The rotate‐plus‐shift C‐arm trajectory. Part I. Complete data with less than 180° rotation | |
| CN107847205B (zh) | 医疗用设备 | |
| Fernández-Barat et al. | Comparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patients | |
| Hwang et al. | White light-activated antimicrobial surfaces: effect of nanoparticles type on activity | |
| Weis et al. | Comparison of image quality and radiation dose between an image-intensifier system and a newer-generation flat-panel detector system—technical phantom measurements and evaluation of clinical imaging in children | |
| Nagata et al. | In vivo 3D analysis of systemic effects after local heavy-ion beam irradiation in an animal model | |
| Astolfo et al. | A simple way to track single gold-loaded alginate microcapsules using x-ray CT in small animal longitudinal studies | |
| Koch et al. | Technical set‐up and case illustrations of orthopaedic cone beam computed tomography in the standing horse | |
| Ning et al. | A novel cone beam breast CT scanner: System evaluation | |
| Karius et al. | Cone‐beam CT imaging with laterally enlarged field of view based on independently movable source and detector | |
| Buerke et al. | Microbiologic contamination of automatic injectors at MDCT: experimental and clinical investigations | |
| Gamaletsou et al. | Experimental Candida albicans osteomyelitis: Microbiologic, antigenic, histologic, and 18FDG-PET-CT imaging characteristics in a newly established rabbit model | |
| Scanga et al. | In vivo imaging in an ABSL-3 regional biocontainment laboratory | |
| Ball et al. | Synchrotron X-ray fluorescence microscopy of gallium in bladder tissue following gallium maltolate administration during urinary tract infection | |
| Buerke et al. | Microbiologic contamination and time efficiency of use of automatic MDCT injectors with prefilled syringes: results of a clinical investigation | |
| US20120183127A1 (en) | Portable radiography imaging system | |
| US20210000435A1 (en) | Anatomical imaging system with centipede belt drive |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E701 | Decision to grant or registration of patent right | ||
| REGI | Registration of establishment |